Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1213

1.

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.

Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Lichinitser M, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Maio M, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan P, Ibrahim N, Marreaud S, van Akkooi ACJ, Suciu S, Robert C.

N Engl J Med. 2018 Apr 15. doi: 10.1056/NEJMoa1802357. [Epub ahead of print]

2.

Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system.

Jiang W, Muhammad F, Ma P, Liu X, Long G.

Antiviral Res. 2018 Apr 10;154:51-57. doi: 10.1016/j.antiviral.2018.04.007. [Epub ahead of print]

PMID:
29653132
3.

Amalgamation of systemic inflammatory response syndrome score with C-reactive protein level in evaluating acute pancreatitis severity in children.

Zheng W, Zhang L, Long G, Chen B, Shu X, Jiang M.

Scand J Gastroenterol. 2018 Apr 12:1-5. doi: 10.1080/00365521.2018.1459825. [Epub ahead of print]

PMID:
29644912
4.

Hepatic CREBZF Couples Insulin to Lipogenesis by Inhibiting Insig activity and Contributes to Hepatic Steatosis in Diet-Induced Insulin-Resistant Mice.

Zhang F, Hu Z, Li G, Huo S, Ma F, Cui A, Xue Y, Han Y, Gong Q, Gao J, Bian H, Meng Z, Wu H, Long G, Tan Y, Zhang Y, Lin X, Gao X, Xu A, Li Y.

Hepatology. 2018 Apr 10. doi: 10.1002/hep.29926. [Epub ahead of print]

PMID:
29637572
5.

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.

Long GV, Atkinson V, Lo S, Sandhu S, Guminski AD, Brown MP, Wilmott JS, Edwards J, Gonzalez M, Scolyer RA, Menzies AM, McArthur GA.

Lancet Oncol. 2018 Mar 27. pii: S1470-2045(18)30139-6. doi: 10.1016/S1470-2045(18)30139-6. [Epub ahead of print]

PMID:
29602646
6.

CD103+ tumor-resident CD8+ T cells are associated with improved survival in immunotherapy naive melanoma patients and expand significantly during anti-PD1 treatment.

Edwards J, Wilmott JS, Madore J, Gide TN, Quek C, Tasker A, Ferguson AL, Chen J, Hewavisenti R, Hersey P, Gebhardt T, Weninger W, Britton WJ, Saw R, Thompson JF, Menzies AM, Long GV, Scolyer RA, Palendira U.

Clin Cancer Res. 2018 Mar 29. pii: clincanres.2257.2017. doi: 10.1158/1078-0432.CCR-17-2257. [Epub ahead of print]

PMID:
29599411
7.

Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124].

Valpione S, Carlino MS, Mangana J, Mooradian MJ, McArthur G, Schadendorf D, Hauschild A, Menzies AM, Arance A, Ascierto PA, Giacomo AD, de Rosa F, Larkin J, Park JJ, Goldinger SM, Sullivan RJ, Xu W, Livingstone E, Weichenthal M, Rai R, Gaba L, Long GV, Lorigan P.

Eur J Cancer. 2018 Apr;93:158. doi: 10.1016/j.ejca.2018.02.001. Epub 2018 Mar 13. No abstract available.

PMID:
29548533
8.

Use of Severity Grades to Characterize Histopathologic Changes.

Schafer KA, Eighmy J, Fikes JD, Halpern WG, Hukkanen RR, Long GG, Meseck EK, Patrick DJ, Thibodeau MS, Wood CE, Francke S.

Toxicol Pathol. 2018 Jan 1:192623318761348. doi: 10.1177/0192623318761348. [Epub ahead of print]

PMID:
29529947
9.

Single phonon source based on a giant polariton nonlinear effect.

Cai K, Pan ZW, Wang RX, Ruan D, Yin ZQ, Long GL.

Opt Lett. 2018 Mar 1;43(5):1163-1166. doi: 10.1364/OL.43.001163.

PMID:
29489805
10.

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.

McQuade JL, Daniel CR, Hess KR, Mak C, Wang DY, Rai RR, Park JJ, Haydu LE, Spencer C, Wongchenko M, Lane S, Lee DY, Kaper M, McKean M, Beckermann KE, Rubinstein SM, Rooney I, Musib L, Budha N, Hsu J, Nowicki TS, Avila A, Haas T, Puligandla M, Lee S, Fang S, Wargo JA, Gershenwald JE, Lee JE, Hwu P, Chapman PB, Sosman JA, Schadendorf D, Grob JJ, Flaherty KT, Walker D, Yan Y, McKenna E, Legos JJ, Carlino MS, Ribas A, Kirkwood JM, Long GV, Johnson DB, Menzies AM, Davies MA.

Lancet Oncol. 2018 Mar;19(3):310-322. doi: 10.1016/S1470-2045(18)30078-0. Epub 2018 Feb 12.

11.

Adjuvant Therapy in Resected Melanoma.

Long GV, Hauschild A, Kirkwood JM.

N Engl J Med. 2018 Feb 15;378(7):679-680. doi: 10.1056/NEJMc1716071. No abstract available.

12.

Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti-Programmed Cell Death 1 Antibodies.

Lee JH, Long GV, Menzies AM, Lo S, Guminski A, Whitbourne K, Peranec M, Scolyer R, Kefford RF, Rizos H, Carlino MS.

JAMA Oncol. 2018 Feb 8:e175332. doi: 10.1001/jamaoncol.2017.5332. [Epub ahead of print]

PMID:
29423503
13.

Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.

Star P, Goodwin A, Kapoor R, Conway RM, Long GV, Scolyer RA, Guitera P.

Eur J Cancer. 2018 Mar;92:48-53. doi: 10.1016/j.ejca.2017.12.022. Epub 2018 Feb 3.

PMID:
29413689
14.

Cotransplantation of Mesenchymal Stem Cells and Immature Dendritic Cells Potentiates the Blood Glucose Control of Islet Allografts.

Long G, Zhang G, Zhang F, Li M, Ye D, Yang D, Yang Y.

Biomed Res Int. 2017;2017:4107943. doi: 10.1155/2017/4107943. Epub 2017 Dec 19.

15.

Metabolic syndrome affects narrow-band UVB phototherapy response in patients with psoriasis.

Rui W, Xiangyu D, Fang X, Long G, Yi Y, Wenjuan W, Tian H, Xiaoning Z, Yong Z, Jianfeng F, Hengjin L, Chengxin L.

Medicine (Baltimore). 2017 Dec;96(50):e8677. doi: 10.1097/MD.0000000000008677.

16.

Engineering yeast for the production of breviscapine by genomic analysis and synthetic biology approaches.

Liu X, Cheng J, Zhang G, Ding W, Duan L, Yang J, Kui L, Cheng X, Ruan J, Fan W, Chen J, Long G, Zhao Y, Cai J, Wang W, Ma Y, Dong Y, Yang S, Jiang H.

Nat Commun. 2018 Jan 31;9(1):448. doi: 10.1038/s41467-018-02883-z.

17.

Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis.

De Sousa SMC, Sheriff N, Tran CH, Menzies AM, Tsang VHM, Long GV, Tonks KTT.

Pituitary. 2018 Jan 29. doi: 10.1007/s11102-018-0866-6. [Epub ahead of print]

PMID:
29380110
18.

Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study.

Valpione S, Carlino MS, Mangana J, Mooradian MJ, McArthur G, Schadendorf D, Hauschild A, Menzies AM, Arance A, Ascierto PA, Di Giacomo A, de Rosa F, Larkin J, Park JJ, Goldinger SM, Sullivan RJ, Xu W, Livingstone E, Weichenthal M, Rai R, Gaba L, Long GV, Lorigan P.

Eur J Cancer. 2018 Mar;91:116-124. doi: 10.1016/j.ejca.2017.12.007. Epub 2018 Jan 19. Erratum in: Eur J Cancer. 2018 Mar 13;:.

19.

Impact of genomics on the surgical management of melanoma.

Ferguson PM, Long GV, Scolyer RA, Thompson JF.

Br J Surg. 2018 Jan;105(2):e31-e47. doi: 10.1002/bjs.10751. Review.

PMID:
29341162
20.

High response rate to PD-1 blockade in desmoplastic melanomas.

Eroglu Z, Zaretsky JM, Hu-Lieskovan S, Kim DW, Algazi A, Johnson DB, Liniker E, Ben Kong, Munhoz R, Rapisuwon S, Gherardini PF, Chmielowski B, Wang X, Shintaku IP, Wei C, Sosman JA, Joseph RW, Postow MA, Carlino MS, Hwu WJ, Scolyer RA, Messina J, Cochran AJ, Long GV, Ribas A.

Nature. 2018 Jan 18;553(7688):347-350. doi: 10.1038/nature25187. Epub 2018 Jan 10.

PMID:
29320474
21.

Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy.

Tio M, Wang X, Carlino MS, Shivalingam B, Fogarty GB, Guminski AD, Lo S, Hong AM, Menzies AM, Long GV.

Pigment Cell Melanoma Res. 2017 Dec 26. doi: 10.1111/pcmr.12682. [Epub ahead of print]

PMID:
29277979
22.

Mesenchymal Stem Cell-Conditioned Medium Reduces Disease Severity and Immune Responses in Inflammatory Arthritis.

Kay AG, Long G, Tyler G, Stefan A, Broadfoot SJ, Piccinini AM, Middleton J, Kehoe O.

Sci Rep. 2017 Dec 21;7(1):18019. doi: 10.1038/s41598-017-18144-w.

23.

Insurance switching and mismatch between the costs and benefits of new technologies.

Cutler D, Ciarametaro M, Long G, Kirson N, Dubois R.

Am J Manag Care. 2017 Dec;23(12):750-757.

24.

Twin Defect Derived Growth of Atomically Thin MoS2 Dendrites.

Wang J, Cai X, Shi R, Wu Z, Wang W, Long G, Tang Y, Cai N, Ouyang W, Geng P, Chandrashekar BN, Amini A, Wang N, Cheng C.

ACS Nano. 2018 Jan 23;12(1):635-643. doi: 10.1021/acsnano.7b07693. Epub 2017 Dec 20.

PMID:
29253328
25.

Association of tourniquet utilization with blood loss, rehabilitation, and complications in Chinese obese patients undergoing total knee arthroplasty: A retrospective study.

Li Z, Liu D, Long G, Ke G, Xiao A, Tang P, Dong J.

Medicine (Baltimore). 2017 Dec;96(49):e9030. doi: 10.1097/MD.0000000000009030.

26.

Quantum memory and non-demolition measurement of single phonon state with nitrogen-vacancy centers ensemble.

Wang RX, Cai K, Yin ZQ, Long GL.

Opt Express. 2017 Nov 27;25(24):30149-30161. doi: 10.1364/OE.25.030149.

PMID:
29221048
27.

Fine-Tuning the Energy Levels of a Nonfullerene Small-Molecule Acceptor to Achieve a High Short-Circuit Current and a Power Conversion Efficiency over 12% in Organic Solar Cells.

Kan B, Zhang J, Liu F, Wan X, Li C, Ke X, Wang Y, Feng H, Zhang Y, Long G, Friend RH, Bakulin AA, Chen Y.

Adv Mater. 2018 Jan;30(3). doi: 10.1002/adma.201704904. Epub 2017 Dec 4.

PMID:
29205535
28.

A prescribed walking regimen plus arginine supplementation improves function and quality of life for patients with pulmonary arterial hypertension: a pilot study.

Brown MB, Kempf A, Collins CM, Long GM, Owens M, Gupta S, Hellman Y, Wong V, Farber M, Lahm T.

Pulm Circ. 2018 Jan-Mar;8(1):2045893217743966. doi: 10.1177/2045893217743966.

29.

Observation of A Raman mode splitting in few layer black phosphorus encapsulated with hexagonal boron nitride.

Urban JM, Baranowski M, Surrente A, Wlodarczyk D, Suchocki A, Long G, Wang Y, Klopotowski L, Wang N, Maude DK, Plochocka P.

Nanoscale. 2017 Dec 14;9(48):19298-19303. doi: 10.1039/c7nr05588a.

PMID:
29192915
30.

Correction for Yang et al., "Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection".

Yang Z, Wang X, Chi X, Zhao F, Guo J, Ma P, Zhong J, Niu J, Pan X, Long G.

J Virol. 2017 Nov 30;91(24). pii: e01642-17. doi: 10.1128/JVI.01642-17. Print 2017 Dec 15. No abstract available.

31.

The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma.

Scott ES, Long GV, Guminski A, Clifton-Bligh RJ, Menzies AM, Tsang VH.

Eur J Endocrinol. 2018 Feb;178(2):175-182. doi: 10.1530/EJE-17-0810. Epub 2017 Nov 29.

PMID:
29187509
32.

Effects of soluble fiber inclusion in gestation diets with varying fermentation characteristics on lactational feed intake of sows over two successive parities.

Tan CQ, Sun HQ, Wei HK, Tan JJ, Long G, Jiang SW, Peng J.

Animal. 2017 Nov 29:1-8. doi: 10.1017/S1751731117003019. [Epub ahead of print]

PMID:
29183414
33.

Metastasis-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanoma.

Lee JHJ, Lyle M, Menzies AM, Chan MMK, Lo S, Clements A, Carlino MS, Kefford RF, Long GV.

Pigment Cell Melanoma Res. 2018 May;31(3):404-410. doi: 10.1111/pcmr.12675. Epub 2017 Dec 7.

PMID:
29171176
34.

Association between Extreme Values of Markers of Chronic Kidney Disease: Mineral and Bone Disorder and 5-Year Mortality among Prevalent Hemodialysis Patients.

Zhu JG, Chen JB, Cheng BC, Lee CH, Long G, Chien YS.

Blood Purif. 2017 Nov 22;45(1-3):1-7. doi: 10.1159/000478972. [Epub ahead of print]

35.

Gate-tunable strong-weak localization transition in few-layer black phosphorus.

Long G, Xu S, Cai X, Wu Z, Han T, Lin J, Cheng C, Cai Y, Wang X, Wang N.

Nanotechnology. 2018 Jan 19;29(3):035204. doi: 10.1088/1361-6528/aa9bc1.

PMID:
29155410
36.

Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients.

Lim SY, Lee JH, Welsh SJ, Ahn SB, Breen E, Khan A, Carlino MS, Menzies AM, Kefford RF, Scolyer RA, Long GV, Rizos H.

Biomark Res. 2017 Nov 10;5:32. doi: 10.1186/s40364-017-0112-9. eCollection 2017.

37.

Notch1 ablation radiosensitizes glioblastoma cells.

Han N, Hu G, Shi L, Long G, Yang L, Xi Q, Guo Q, Wang J, Dong Z, Zhang M.

Oncotarget. 2017 Sep 30;8(50):88059-88068. doi: 10.18632/oncotarget.21409. eCollection 2017 Oct 20.

38.

Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma.

Gide TN, Wilmott JS, Scolyer RA, Long GV.

Clin Cancer Res. 2018 Mar 15;24(6):1260-1270. doi: 10.1158/1078-0432.CCR-17-2267. Epub 2017 Nov 10. Review.

PMID:
29127120
39.

High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.

Sivaraj D, Bacon W, Long GD, Rizzieri DA, Horwitz ME, Sullivan KM, Kang Y, Li Z, Chao NJ, Gasparetto C.

Bone Marrow Transplant. 2018 Jan;53(1):34-38. doi: 10.1038/bmt.2017.208. Epub 2017 Oct 30.

PMID:
29084203
40.

Histopathology of pembrolizumab-induced hepatitis: a case report.

Aivazian K, Long GV, Sinclair EC, Kench JG, McKenzie CA.

Pathology. 2017 Dec;49(7):789-792. doi: 10.1016/j.pathol.2017.07.010. Epub 2017 Nov 1. No abstract available.

PMID:
29079004
41.

Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.

Glodde N, Bald T, van den Boorn-Konijnenberg D, Nakamura K, O'Donnell JS, Szczepanski S, Brandes M, Eickhoff S, Das I, Shridhar N, Hinze D, Rogava M, van der Sluis TC, Ruotsalainen JJ, Gaffal E, Landsberg J, Ludwig KU, Wilhelm C, Riek-Burchardt M, Müller AJ, Gebhardt C, Scolyer RA, Long GV, Janzen V, Teng MWL, Kastenmüller W, Mazzone M, Smyth MJ, Tüting T, Hölzel M.

Immunity. 2017 Oct 17;47(4):789-802.e9. doi: 10.1016/j.immuni.2017.09.012.

PMID:
29045907
42.

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.

Pollack MH, Betof A, Dearden H, Rapazzo K, Valentine I, Brohl AS, Ancell KK, Long GV, Menzies AM, Eroglu Z, Johnson DB, Shoushtari AN.

Ann Oncol. 2018 Jan 1;29(1):250-255. doi: 10.1093/annonc/mdx642.

PMID:
29045547
43.

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF; for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform.

CA Cancer J Clin. 2017 Nov;67(6):472-492. doi: 10.3322/caac.21409. Epub 2017 Oct 13.

44.

Radiological manifestations of immune-related adverse effects observed in patients with melanoma undergoing immunotherapy.

Sidhu P, Menzies AM, Long G, Carlino M, Lorens S, Kapoor R.

J Med Imaging Radiat Oncol. 2017 Dec;61(6):759-766. doi: 10.1111/1754-9485.12653. Epub 2017 Oct 11.

PMID:
29024572
45.

Isolation and Characterization of Few-Layer Manganese Thiophosphite.

Long G, Zhang T, Cai X, Hu J, Cho CW, Xu S, Shen J, Wu Z, Han T, Lin J, Wang J, Cai Y, Lortz R, Mao Z, Wang N.

ACS Nano. 2017 Nov 28;11(11):11330-11336. doi: 10.1021/acsnano.7b05856. Epub 2017 Oct 16.

PMID:
29023097
46.

Measurement of linear response functions in Nuclear Magnetic Resonance.

Xin T, Pedernales JS, Lamata L, Solano E, Long GL.

Sci Rep. 2017 Oct 9;7(1):12797. doi: 10.1038/s41598-017-13037-4.

47.

Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib.

Long GV, Eroglu Z, Infante J, Patel S, Daud A, Johnson DB, Gonzalez R, Kefford R, Hamid O, Schuchter L, Cebon J, Sharfman W, McWilliams R, Sznol M, Redhu S, Gasal E, Mookerjee B, Weber J, Flaherty KT.

J Clin Oncol. 2018 Mar 1;36(7):667-673. doi: 10.1200/JCO.2017.74.1025. Epub 2017 Oct 9.

PMID:
28991513
48.

Leptomeningeal melanoma-A case series in the era of modern systemic therapy.

Arasaratnam M, Hong A, Shivalingam B, Wheeler H, Guminksi AD, Long GV, Menzies AM.

Pigment Cell Melanoma Res. 2018 Jan;31(1):120-124. doi: 10.1111/pcmr.12652. Epub 2017 Oct 17. No abstract available.

PMID:
28976629
49.

[A semimicroquality evaluation method on Panax notoginseng and its application in analysis of continuous cropping obstacles research samples].

Cao Y, Wang CQ, Xu F, Jia XH, Liu GX, Yang SC, Long GQ, Chen ZJ, Wei FZ, Yang SZ, Fukuda K, Wang X, Cai SQ.

Zhongguo Zhong Yao Za Zhi. 2016 Oct;41(20):3773-3781. doi: 10.4268/cjcmm20162012. Chinese.

PMID:
28929655
50.

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

Somasundaram R, Zhang G, Fukunaga-Kalabis M, Perego M, Krepler C, Xu X, Wagner C, Hristova D, Zhang J, Tian T, Wei Z, Liu Q, Garg K, Griss J, Hards R, Maurer M, Hafner C, Mayerhöfer M, Karanikas G, Jalili A, Bauer-Pohl V, Weihsengruber F, Rappersberger K, Koller J, Lang R, Hudgens C, Chen G, Tetzlaff M, Wu L, Frederick DT, Scolyer RA, Long GV, Damle M, Ellingsworth C, Grinman L, Choi H, Gavin BJ, Dunagin M, Raj A, Scholler N, Gross L, Beqiri M, Bennett K, Watson I, Schaider H, Davies MA, Wargo J, Czerniecki BJ, Schuchter L, Herlyn D, Flaherty K, Herlyn M, Wagner SN.

Nat Commun. 2017 Sep 19;8(1):607. doi: 10.1038/s41467-017-00452-4.

Supplemental Content

Support Center